Financial Events

31 August 2021

Interim Financial Report H1, 2021

Financial
09 June 2021

Annual Shareholders’ Meeting

Financial
Shareholders' meeting
09 April 2021

Full Year 2020 Financial and Operating Results

Please click here to hear the archived presentation.

Financial
Read more

Financial Downloads

SEC Filings

Special Reports

Special auditor report – Articles 7:179, 7:191 and 7:193 CCA (Nasdaq IPO)

Special Reports
Download (FR)

Special auditor report – Articles 7:180 juncto 7:179 and 7:191 CCA (2021 Warrants plan)

Special Reports
Download (FR)

All rights reserved © 2021 Nyxoah SA. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah SA. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020

Privacy Notice
Cookie Policy
 Cookie Settings
bubble
bubble
bubble
bubble
bubble